Amarin Corporation plc (AMRN) is trading at $16.84, up 33.72 percent, or $4.24 on Tuesday, after announcing a major licensing and supply agreement with Recordati to commercialize Vazkepa across 59 countries, primarily in Europe.
The stock opened at $13.80 and has traded between $13.80 and $17.11 so far today on the Nasdaq. Current volume stands at 914,657, well above the average of 97,474. Amarin's 52-week trading range is $7.00 to $17.11.
Recordati will pay Amarin $25 million upfront, with potential commercial milestones of up to $150 million tied to future sales thresholds, alongside royalties for product supply.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.